• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nature . Human germinal centres engage memory and naive B cells after influenza vaccination

tetano

Editor, Senior Moderator
Nature


. 2020 Aug 31.
doi: 10.1038/s41586-020-2711-0. Online ahead of print.
Human germinal centres engage memory and naive B cells after influenza vaccination


Jackson S Turner[SUP] 1 [/SUP], Julian Q Zhou[SUP] 2 [/SUP], Julianna Han[SUP] 3 [/SUP], Aaron J Schmitz[SUP] 1 [/SUP], Amena A Rizk[SUP] 1 [/SUP], Wafaa B Alsoussi[SUP] 1 [/SUP], Tingting Lei[SUP] 1 [/SUP], Mostafa Amor[SUP] 1 [/SUP], Katherine M McIntire[SUP] 1 [/SUP], Philip Meade[SUP] 4 5 [/SUP], Shirin Strohmeier[SUP] 4 [/SUP], Rafael I Brent[SUP] 1 [/SUP], Sara T Richey[SUP] 3 [/SUP], Alem Haile[SUP] 6 [/SUP], Yuhe R Yang[SUP] 3 [/SUP], Michael K Klebert[SUP] 6 [/SUP], Teresa Suessen[SUP] 7 [/SUP], Sharlene Teefey[SUP] 7 [/SUP], Rachel M Presti[SUP] 8 [/SUP], Florian Krammer[SUP] 4 [/SUP], Steven H Kleinstein[SUP] 2 9 [/SUP], Andrew B Ward[SUP] 3 [/SUP], Ali H Ellebedy[SUP] 10 11 [/SUP]



Affiliations

Abstract

Influenza viruses remain a major public health threat. Seasonal influenza vaccination in humans primarily stimulates pre-existing memory B cells, leading to a transient wave of circulating antibody-secreting plasmablasts[SUP]1-3[/SUP]. This recall response contributes to "original antigenic sin," the selective boosting of antibody specificities from prior exposures to influenza virus antigens[SUP]4[/SUP]. It remains unclear whether such vaccination can also induce germinal centre (GC) reactions in the draining lymph node (LN) where diversification and maturation of recruited B cells can occur[SUP]5[/SUP]. Here we used ultrasound-guided fine needle aspiration to serially sample the draining LNs and investigate the dynamics and specificity of GC B cell responses after influenza vaccination in humans. We show that influenza vaccine-binding GC B cells can be detected as early as 1 week after vaccination. In 3 out of 8 participants, we detected vaccine-binding GC B cells up to 9 weeks after vaccination. Between 12% and 88% of the responding GC B cell clones overlapped with those detected among early circulating plasmablasts. These shared B cell clones had high frequencies of somatic hypermutation (SHM) and encoded broadly cross-reactive monoclonal antibodies (mAbs). In contrast, vaccine-induced B cell clones detected only in the GC compartment exhibited significantly lower SHM frequencies and predominantly encoded strain-specific mAbs, suggesting a naive B cell origin. Electron microscopy-based epitope mapping revealed that some of these strain-specific mAbs recognized epitopes that were not targeted by the early plasmablast response. Our results indicate that influenza virus vaccination of humans can elicit a GC reaction to which B cell clones targeting novel epitopes are more likely to be recruited, thereby broadening the spectrum of vaccine-induced protective antibodies against this rapidly mutating pathogen.
 
Back
Top Bottom